Press Release - September 16th, 2024 SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities Austin, TX, September 17, 2024 — SubjectWell, provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies. The integration of Press Release - April 30th, 2024 WindRose Health Investors Completes Majority Growth Investment in SubjectWell New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision Press Release - November 14th, 2023 SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which specifies Press Release - November 1st, 2023 SubjectWell Acquires PatientCentra Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers News - June 2nd, 2023 SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - April 30th, 2024 WindRose Health Investors Completes Majority Growth Investment in SubjectWell New York, NY, April 30, 2024 — WindRose Health Investors, LLC, (“Windrose”) the New York-based healthcare private equity firm, announced that it has completed the acquisition of SubjectWell, the patient access marketplace that connects people with health conditions to care options. The terms of the transaction were not disclosed. Using a multi-channel network and precision Press Release - November 14th, 2023 SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which specifies Press Release - November 1st, 2023 SubjectWell Acquires PatientCentra Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers News - June 2nd, 2023 SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - November 14th, 2023 SubjectWell Receives System and Organization Controls (SOC) 2 Type 2 Certification The patient access marketplace successfully demonstrated strong data security credentials throughout comprehensive assessment AUSTIN, TX, November 14, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced it has received its System and Organization Controls (SOC) 2 Type 2 certification, a voluntary compliance standard which specifies Press Release - November 1st, 2023 SubjectWell Acquires PatientCentra Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers News - June 2nd, 2023 SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - November 1st, 2023 SubjectWell Acquires PatientCentra Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers News - June 2nd, 2023 SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - June 2nd, 2023 SubjectWell: This Patient Connection Platform Is Aiming To Transform A $2.4 Billion Market Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - April 6th, 2023 SubjectWell Expands Executive Leadership to Realize Growth Strategy AUSTIN, TX, April 6, 2023 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO. After an extensive year-long search for a proven leader with the right combination of experience accelerating technical solutions and building investor News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - February 2nd, 2023 Making Clinical Trials Better for Everyone in 2023 Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - November 10th, 2022 US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently announced a R630 Million ($35 million USD) Series B funding round led by Asset Management Ventures. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - November 3rd, 2022 Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase. News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - October 24th, 2022 Clinical trial recruitment platform SubjectWell scores $35M News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - October 21st, 2022 SubjectWell collects $35M News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - October 20th, 2022 SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases Read full article from Austin Inno Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - October 18th, 2022 SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - October 11th, 2022 Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - August 18th, 2022 Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S. News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - August 2nd, 2022 Bilingual staff boost Spanish speaker interest in trials: study News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - April 11th, 2022 SubjectWell expands trial recruitment marketplace to oncology indications Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - March 16th, 2022 SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). The company is leveraging its proven clinical trial marketplace, which has been used to reach patients across more than 175 therapeutic News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - February 16th, 2022 Younger Parkinson’s Patients Show Strong Interest in Trial Participation (DOWNLOAD) News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - October 5th, 2021 Rise of DCTs calls for elevated patient recruitment strategy News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - September 14th, 2021 How decentralized clinical trials disrupt traditional patient recruitment News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - August 31st, 2021 Tech startups are raising millions to diversify clinical trials. But experts say the problem runs deeper than technology. News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
News - May 24th, 2021 Reify, SubjectWell partner to elevate trial recruitment Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts Solutions Patient Recruitment Guided Recruitment Direct Connect Virtual Waiting Room Recruitment Agency Performance Marketing Brand Connect Who We Help Sponsors CROs Brand Marketers Company Company About Us Work with Us Partner with Us News and Research News Blog & Research Contact Us Client Login
Press Release - March 31st, 2021 Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical trials marketplace, today announced an innovative partnership aimed at streamlining the workflow of research sites to manage patient referrals from sponsor-driven recruitment campaigns. With this pairing, referrals from SubjectWell’s News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts
News - January 26th, 2021 Survey reveals thoughts on trial participation from patients at-risk for liver disease « Previous Posts